JP2009532338A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009532338A5 JP2009532338A5 JP2009500598A JP2009500598A JP2009532338A5 JP 2009532338 A5 JP2009532338 A5 JP 2009532338A5 JP 2009500598 A JP2009500598 A JP 2009500598A JP 2009500598 A JP2009500598 A JP 2009500598A JP 2009532338 A5 JP2009532338 A5 JP 2009532338A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- amino
- hydroxy
- pharmaceutically acceptable
- acceptable salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US78221106P | 2006-03-14 | 2006-03-14 | |
| PCT/US2007/064002 WO2007106869A1 (en) | 2006-03-14 | 2007-03-14 | Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009532338A JP2009532338A (ja) | 2009-09-10 |
| JP2009532338A5 true JP2009532338A5 (enExample) | 2011-04-28 |
Family
ID=38229662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009500598A Pending JP2009532338A (ja) | 2006-03-14 | 2007-03-14 | Ｐｓｍａのペプチド模倣体阻害剤、それらを含む化合物、およびそれらの使用方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (3) | US7696185B2 (enExample) |
| EP (1) | EP1999136B1 (enExample) |
| JP (1) | JP2009532338A (enExample) |
| CN (1) | CN101443340B (enExample) |
| AU (1) | AU2007226542B2 (enExample) |
| CA (1) | CA2645809C (enExample) |
| ES (1) | ES2397973T3 (enExample) |
| PL (1) | PL1999136T3 (enExample) |
| WO (1) | WO2007106869A1 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2926573C (en) * | 2007-06-26 | 2018-08-28 | The Johns Hopkins University | Labeled inhibitors of prostate specific membrane antigen (psma), biological evaluation, and use as imaging agents |
| US9193763B2 (en) | 2007-08-17 | 2015-11-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
| WO2010045598A2 (en) * | 2008-10-17 | 2010-04-22 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| WO2010149666A1 (en) * | 2009-06-22 | 2010-12-29 | Medexis S.A. | Methods for treating neoplasia |
| EP2338892A1 (en) | 2009-12-18 | 2011-06-29 | Bayer Schering Pharma Aktiengesellschaft | Prostate specific membrane antigen inhibitors |
| US9951324B2 (en) | 2010-02-25 | 2018-04-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
| WO2011106639A1 (en) * | 2010-02-25 | 2011-09-01 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| JP5657902B2 (ja) * | 2010-03-17 | 2015-01-21 | 株式会社コスモステクニカルセンター | ポリオキシアルキレンステロールエーテル誘導体及び／又はポリオキシアルキレンスタノールエーテル誘導体、及びそれを含有する外用剤組成物 |
| US9328129B2 (en) | 2010-11-12 | 2016-05-03 | Washington State University | Peptidomimetic inhibitors of PSMA |
| CN103930432B (zh) * | 2011-06-15 | 2017-06-23 | 癌靶技术有限责任公司 | 螯合的psma抑制剂 |
| WO2013173583A1 (en) | 2012-05-16 | 2013-11-21 | Cancer Targeted Technology, Llc | Psma inhibitors |
| AU2013344778C1 (en) | 2012-11-15 | 2024-06-27 | Endocyte, Inc. | Conjugates for treating diseases caused by PSMA expressing cells |
| EP2970345B1 (en) | 2013-03-15 | 2019-06-19 | Cancer Targeted Technology LLC | 18f-labeled psma-targeted pet imaging agents |
| EP2842578B1 (en) * | 2013-08-27 | 2018-06-27 | GILUPI GmbH | Diagnostic device for the detection of biomarkers |
| EP3456700A1 (en) | 2013-10-18 | 2019-03-20 | Deutsches Krebsforschungszentrum | Labeled inhibitors of prostate specific membrane antigen (psma), their use as imaging agents and pharmaceutical agents for the treatment of prostate cancer |
| CN105849568B (zh) | 2013-11-14 | 2018-05-04 | 恩多塞特公司 | 用于正电子发射断层术的化合物 |
| US10383912B2 (en) * | 2014-08-18 | 2019-08-20 | Washington State University | Tunable pH-sensitive linker for controlled drug release |
| US10188759B2 (en) | 2015-01-07 | 2019-01-29 | Endocyte, Inc. | Conjugates for imaging |
| US9808538B2 (en) * | 2015-09-09 | 2017-11-07 | On Target Laboratories, LLC | PSMA-targeted NIR dyes and their uses |
| WO2018031809A1 (en) | 2016-08-10 | 2018-02-15 | Cancer Targeted Technology Llc | Chelated psma inhibitors |
| KR20210003135A (ko) | 2018-04-17 | 2021-01-11 | 엔도사이트, 인코포레이티드 | 암의 치료 방법 |
| IL287989B2 (en) * | 2019-05-13 | 2025-07-01 | Bracco Imaging Spa | Modified cyanine dyes and their conjugates |
| JP7604397B2 (ja) | 2019-05-20 | 2024-12-23 | エンドサイト・インコーポレイテッド | Ｐｓｍａコンジュゲートの調製方法 |
| WO2021046233A1 (en) | 2019-09-03 | 2021-03-11 | Cancer Targeted Technology Llc | Chelate-containing psma inhibitors |
| CN113117099B (zh) * | 2019-12-31 | 2022-07-15 | 广东精观生物医药科技有限公司 | 一种靶向psma的荧光分子探针及其制备方法和应用 |
| CN111675747B (zh) * | 2020-07-30 | 2021-04-27 | 中国医学科学院医药生物技术研究所 | 抗肿瘤药物和用途 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US782211A (en) | 1904-05-23 | 1905-02-07 | George W Sturgis | Vending-wagon. |
| TR199802638T2 (xx) * | 1996-06-17 | 1999-03-22 | Guilford Pharmaceuticals, Inc. | Kanser tedavisinde naaladase inhibit�rleri kullan�m�. |
| WO2002046448A2 (en) * | 2000-11-20 | 2002-06-13 | Eastern Virginia Medical School | Methods and devices for the quantitative detection of prostate specific membrane antigen and other prostatic markers |
| WO2002098885A1 (en) * | 2001-02-07 | 2002-12-12 | Beth Israel Deaconess Medical Center | Modified psma ligands and uses related thereto |
| KR20040077889A (ko) * | 2002-01-28 | 2004-09-07 | 메다렉스, 인코포레이티드 | 전립선 특이적 막 항원 (ｐｓｍａ)에 대한 인간모노클로날 항체 |
-
2007
- 2007-03-14 ES ES07758547T patent/ES2397973T3/es active Active
- 2007-03-14 US US11/686,272 patent/US7696185B2/en not_active Ceased
- 2007-03-14 PL PL07758547T patent/PL1999136T3/pl unknown
- 2007-03-14 CN CN2007800176204A patent/CN101443340B/zh active Active
- 2007-03-14 JP JP2009500598A patent/JP2009532338A/ja active Pending
- 2007-03-14 AU AU2007226542A patent/AU2007226542B2/en active Active
- 2007-03-14 EP EP07758547A patent/EP1999136B1/en active Active
- 2007-03-14 WO PCT/US2007/064002 patent/WO2007106869A1/en not_active Ceased
- 2007-03-14 CA CA2645809A patent/CA2645809C/en active Active
-
2010
- 2010-01-22 US US12/691,957 patent/US8293725B2/en active Active
- 2010-07-13 US US12/835,257 patent/USRE42275E1/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102658933B1 (ko) | 이중 표적화 화합물 및 이의 제조 방법과 응용 | |
| US8765096B2 (en) | Methods and compositions for treating and diagnosing kidney disease | |
| ES2397973T3 (es) | Inhibidores peptidomiméticos del PSMA, compuestos que los comprenden y métodos de utilización | |
| JP2016153410A5 (enExample) | ||
| US20210206774A1 (en) | Molecular containers and methods of making and using same | |
| CN103260652B (zh) | 显示不依赖于浓度的响应性的cest系统 | |
| US7998462B2 (en) | Linkers for anchoring targeting ligands | |
| US20100183658A1 (en) | Novel Compounds for Enhancing MHC Class II Therapies | |
| JP2019519530A (ja) | ペグ化されたカルフィルゾミブ化合物 | |
| JP2010174013A (ja) | 組織ダメージの治療と予防 | |
| US20250177540A1 (en) | Stable compositions of pegylated carfilzomib compounds | |
| JP2014516993A5 (enExample) | ||
| KR20120047263A (ko) | ε폴리라이신 결합체 및 이의 용도 | |
| US10702546B2 (en) | Bile acid oligomer conjugate for novel vesicular transport and use thereof | |
| JP2011523669A (ja) | 生分解性金属キレート化ポリマーおよびワクチン | |
| RU2012124266A (ru) | Хелаты марганца и их применение в качестве контрастных агентов в магнитно-резонансной визуализации (mpb) | |
| AU2021259858B2 (en) | GPER proteolytic targeting chimeras | |
| US11414455B2 (en) | Toll-like receptor 2 ligands and methods of making and using thereof | |
| US20240190790A1 (en) | Conjugates derived from non-steroidal anti-inflammatory drugs and methods of use thereof in imaging | |
| CN105188703A (zh) | 荧光-hap：用于细胞中的hbv核的诊断性染色剂 | |
| Urbanovsky et al. | Lanthanide complexes of DO3A–(Dibenzylamino) methylphosphinate: effect of Protonation of the Dibenzylamino Group on the water-exchange rate and the binding of human serum albumin | |
| JP7114074B2 (ja) | 画像化のためのニトロキシドを含むアミロイド結合剤およびその治療的使用 | |
| CA2739445A1 (en) | Site specific n-terminal modifications of proteins and conjugate formation | |
| JP2013532664A5 (enExample) | ||
| JP2014500268A5 (enExample) |